세계의 의료용 특수 백 시장 규모, 점유율, 동향, 예측 : 제품별, 최종사용자별, 지역별(2025-2033년)

The global medical specialty bags market size was valued at USD 12.05 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 17.33 Billion by 2033, exhibiting a CAGR of 3.91% from 2025-2033. North America currently dominates the medical specialty bags market share by holding over 32.8% in 2024. The market is driven by advanced healthcare infrastructure, high prevalence of chronic diseases, growing geriatric population, increasing surgical procedures, and favorable reimbursement policies in the region.

Medical specialty bags refer to portable, high-quality, specially designed bags manufactured from advanced materials, including polyester and polymer films. They aid in maintaining various biological samples in sterilized conditions to avoid leakage and control the spread of diseases caused due to bowel incontinence. On account of these properties, medical specialty bags are extensively used for sterile packaging, eternal feeding, bile gathering and blood and urine sample collection. At present, these bags are commercially available in varying product types, such as continuous ambulatory peritoneal dialysis (CAPD), ice and resuscitation bags.

Medical Specialty Bags Market Trends:

The increasing health consciousness due to the rising prevalence of various chronic diseases, mostly amongst the rising geriatric population, represents one of the prime factors currently driving the medical specialty bags market growth. This is further supported by the increasing need for customer-focused products and services, which, in turn, is facilitating the widespread product adoption across the globe. In line with this, numerous favorable initiatives undertaken by the government bodies of several countries for strengthening the healthcare infrastructure and enhancing the medical standards through the employment of improved reimbursement packages is acting as another growth-inducing factor. Moreover, the escalating demand for polyvinyl chloride (PVC) bags in the healthcare sector on account of their versatility, affordability, and recyclability qualities, is contributing to the market growth. The extensive utilization of intravenous (IV) therapy bags in several applications, such as surgeries, providing nutrition to the patients, sustaining basal hydration levels and maintaining the correct electrolyte balance is further propelling the market growth. Other factors, such as strategic collaborations between key players and continuous investments in the research and development (R&D) activities in the field of medical science for introducing advanced medical tools and accessories, are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Product:

• Anesthesia Breathing Bags
• Blood Bags
• Sterile Packaging Bags
• Ostomy Collection Bags
• Enteral Feeding Bags
• Cadaver Bags
• Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
• Intravenous Fluid Bags
• Others

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers
• Home Healthcare
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ambu A/S, B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Coloplast A/S, ConvaTec Group PLC, Hollister Incorporated, Macopharma, Medline Industries LP, Nolato AB, Pall Corporation (Danaher Corporation), SB-Kawasumi Laboratories Inc. (Sumitomo Bakelite Co. Ltd.) and Terumo Corporation.

Key Questions Answered in This Report

• 1.How big is the medical specialty bags market?
• 2.What is the future outlook of the medical specialty bags market?
• 3.What are the key factors driving the medical specialty bags market?
• 4.Which region accounts for the largest medical specialty bags market share?
• 5.Which are the leading companies in the global medical specialty bags market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Specialty Bags Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Anesthesia Breathing Bags
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Blood Bags
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Sterile Packaging Bags
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Ostomy Collection Bags
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Enteral Feeding Bags
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Cadaver Bags
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast
• 6.8 Intravenous Fluid Bags
  • 6.8.1 Market Trends
  • 6.8.2 Market Forecast
• 6.9 Others
  • 6.9.1 Market Trends
  • 6.9.2 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Ambulatory Surgical Centers
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Home Healthcare
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Ambu A/S
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 B. Braun Melsungen AG
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 SWOT Analysis
  • 13.3.3 Baxter International Inc.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 Becton Dickinson and Company
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Coloplast A/S
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis
  • 13.3.6 ConvaTec Group PLC
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
  • 13.3.7 Hollister Incorporated
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 SWOT Analysis
  • 13.3.8 Macopharma
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 Medline Industries LP
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 SWOT Analysis
  • 13.3.10 Nolato AB
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
    • 13.3.10.3 Financials
  • 13.3.11 Pall Corporation (Danaher Corporation)
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
    • 13.3.11.3 SWOT Analysis
  • 13.3.12 SB-Kawasumi Laboratories Inc. (Sumitomo Bakelite Co. Ltd.)
    • 13.3.12.1 Company Overview
    • 13.3.12.2 Product Portfolio
  • 13.3.13 Terumo Corporation
    • 13.3.13.1 Company Overview
    • 13.3.13.2 Product Portfolio
    • 13.3.13.3 Financials
    • 13.3.13.4 SWOT Analysis